Karyopharm Therapeutics Inc (KPTI)
1.105
+0.08
(+8.33%)
USD |
NASDAQ |
May 09, 14:14
Karyopharm Therapeutics Market Cap: 127.15M for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 117.37M |
| May 07, 2024 | 126.57M |
| May 06, 2024 | 132.33M |
| May 03, 2024 | 130.03M |
| May 02, 2024 | 124.27M |
| May 01, 2024 | 124.27M |
| April 30, 2024 | 118.52M |
| April 29, 2024 | 126.57M |
| April 26, 2024 | 121.97M |
| April 25, 2024 | 121.97M |
| April 24, 2024 | 125.42M |
| April 23, 2024 | 125.42M |
| April 22, 2024 | 130.03M |
| April 19, 2024 | 134.63M |
| April 18, 2024 | 147.29M |
| April 17, 2024 | 158.79M |
| April 16, 2024 | 126.57M |
| April 15, 2024 | 132.90M |
| April 12, 2024 | 140.38M |
| April 11, 2024 | 154.19M |
| April 10, 2024 | 146.14M |
| April 09, 2024 | 154.19M |
| April 08, 2024 | 155.34M |
| April 05, 2024 | 156.49M |
| April 04, 2024 | 153.04M |
| Date | Value |
|---|---|
| April 03, 2024 | 147.86M |
| April 02, 2024 | 160.52M |
| April 01, 2024 | 181.81M |
| March 28, 2024 | 173.75M |
| March 27, 2024 | 170.30M |
| March 26, 2024 | 159.94M |
| March 25, 2024 | 159.94M |
| March 22, 2024 | 159.94M |
| March 21, 2024 | 163.40M |
| March 20, 2024 | 161.09M |
| March 19, 2024 | 157.64M |
| March 18, 2024 | 169.15M |
| March 15, 2024 | 173.75M |
| March 14, 2024 | 154.19M |
| March 13, 2024 | 163.40M |
| March 12, 2024 | 166.85M |
| March 11, 2024 | 170.30M |
| March 08, 2024 | 180.66M |
| March 07, 2024 | 176.05M |
| March 06, 2024 | 153.04M |
| March 05, 2024 | 143.26M |
| March 04, 2024 | 150.74M |
| March 01, 2024 | 136.35M |
| February 29, 2024 | 133.48M |
| February 28, 2024 | 153.04M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
77.40M
Minimum
Nov 29 2023
1.846B
Maximum
Apr 27 2020
628.64M
Average
507.18M
Median
Market Cap Benchmarks
| Geron Corp | 2.304B |
| Arbutus Biopharma Corp | 552.00M |
| Verastem Inc | 300.66M |
| Actinium Pharmaceuticals Inc | 263.58M |
| Chimerix Inc | 90.53M |
Market Cap Related Metrics
| PS Ratio | 0.8643 |
| Price | 1.105 |
| Earnings Yield | -113.1% |